Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Argatroban in Acute Ischemic Stroke With Early Neurological Deterioration

NCT04275180 is registered in ClinicalTrials.gov with Second Affiliated Hospital, Zhejiang University, School of Medicine as lead sponsor.

NCT NCT04275180
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04275180 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Argatroban in Acute Ischemic Stroke With Early Neurological Deterioration
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
March 21, 2020
Completion date
January 31, 2023
Enrollment
628 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

acute progressive ischemic stroke